D-Wave Quantum: Institutional Buyers Quietly Build Positions While Law Firms Circle

Law firms investigate QBTS over CFO exit and insider sales, while Wellington and Manulife raise stakes, betting on quantum growth.

There is a peculiar moment in the lifecycle of a young technology company when two competing narratives run in parallel, each demanding the market's attention. D-Wave Quantum finds itself in exactly that position. Law firms are probing potential securities violations, while institutional investors are increasing their stakes. Both stories are true. Only one will ultimately matter.

Legal Scrutiny Intensifies

The signals from the US legal community began multiplying in early September. Kessler Topaz Meltzer & Check announced on September 3 that it was investigating potential violations of federal securities law on behalf of investors who purchased QBTS shares and suffered losses. Pomerantz LLP followed the same day, examining possible claims related to securities fraud or other unlawful business practices.

Both firms anchor their inquiries to the same set of events: disappointing quarterly results reported on August 6 and the sudden departure of the chief financial officer announced in late August. Media reports indicate that insiders have sold more than one million shares over the past 90 days, including transactions by senior executives and a board member. Whether those sales were governed by pre-arranged trading plans or tax-driven mandatory dispositions remains unclear from available disclosures.

Such investor alerts are a recurring pattern in the United States after any share price decline. Not every announcement leads to an actual lawsuit, let alone a settlement. But they create a persistent noise that shapes how the stock is perceived, particularly when a company is already under scrutiny. The firms cite the insider sales alongside the post-earnings share slide and the CFO transition as part of their review, though no legal finding has been established and no complaint has yet been filed.

Institutional Money Moves the Other Way

While the legal profession investigates, a different set of signals has been ticking across the tape. Wellington Management Group increased its position in D-Wave Quantum, according to a filing cited in early September. Shortly before, on September 1, The Manufacturers Life Insurance Company acquired roughly 204,727 shares valued at approximately $4.9 million.

This is not coincidence but rather characteristic behavior for long-horizon funds. They tend to buy where valuation and volatility have temporarily diverged, without being rattled by legal noise. Whether that calculus proves correct depends on whether D-Wave can actually generate the operational momentum the law firms are calling into question. The insurer's purchase stands in sharp contrast to the insider selling wave, suggesting that patient investors are weighting the company's operational progress more heavily than its short-term turbulence.

A Business Story With Two Sides

The commercial picture that emerged from the second quarter offers ammunition for both camps. Business customers accounted for 62.4 percent of quarterly revenue, subscription revenue from quantum computing services grew 50 percent to $1.9 million, and first-half bookings jumped 1,120 percent. Remaining performance obligations stand at $40.7 million, with roughly 57 percent expected to convert within the next twelve months. The company also completed a $20 million sale of an annealing system to Florida Atlantic University, and a gate-model program milestone is targeted before year-end.

That is the bull case: a quantum computing provider that, despite missing revenue expectations in the second quarter, is filling its order book and signing new contracts with universities and corporations. The bears counter that when a company's accounting and communication appear questionable enough to draw parallel investigations from two law firms, even the most promising pipeline offers little comfort.

What the Share Price Reveals

The stock itself tells a story of persistent skepticism. Shares closed Monday at €14.40, having traded near its 52-week low of €11.12, a level marked as recently as late March. That represents roughly 30 percent upside from the trough but remains miles away from the year's high. The stock is down 36 percent since the start of the year, a figure reflecting the deep caution with which the market currently greets every personnel change and every new data point.

D-Wave's situation is typical of companies straddling the line between future technology and proof of concept. Quantum computing is a field where expectations and reality can diverge dramatically. Every disappointment carries outsized weight, while every contract signing is interpreted as evidence that the technology is closer to market readiness than previously assumed. The company embodies this tension: institutional investors betting on long-term substance, law firms probing short-term cracks. Which side prevails will not be decided on any single trading day, but rather on whether order books translate into revenues that once again exceed expectations rather than fall short of them.